Logo image of BV

BRIGHTVIEW HOLDINGS INC (BV) Stock Fundamental Analysis

NYSE:BV - New York Stock Exchange, Inc. - US10948C1071 - Common Stock - Currency: USD

13.43  +0.04 (+0.3%)

After market: 13.43 0 (0%)

Fundamental Rating

3

BV gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 83 industry peers in the Commercial Services & Supplies industry. BV has a bad profitability rating. Also its financial health evaluation is rather negative. BV is not valued too expensively and it also shows a decent growth rate.


Dividend Valuation Growth Profitability Health

3

1. Profitability

1.1 Basic Checks

In the past year BV was profitable.
In the past year BV had a positive cash flow from operations.
The reported net income has been mixed in the past 5 years: BV reported negative net income in multiple years.
In the past 5 years BV always reported a positive cash flow from operatings.
BV Yearly Net Income VS EBIT VS OCF VS FCFBV Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M -50M 100M 150M 200M

1.2 Ratios

BV's Return On Assets of 0.77% is in line compared to the rest of the industry. BV outperforms 45.78% of its industry peers.
BV has a Return On Equity (1.43%) which is in line with its industry peers.
BV has a Return On Invested Capital of 2.85%. This is comparable to the rest of the industry: BV outperforms 42.17% of its industry peers.
BV had an Average Return On Invested Capital over the past 3 years of 2.40%. This is significantly below the industry average of 10.77%.
The 3 year average ROIC (2.40%) for BV is below the current ROIC(2.85%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.77%
ROE 1.43%
ROIC 2.85%
ROA(3y)0.26%
ROA(5y)0.17%
ROE(3y)0.6%
ROE(5y)0.4%
ROIC(3y)2.4%
ROIC(5y)2.06%
BV Yearly ROA, ROE, ROICBV Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 -4 -6

1.3 Margins

The Profit Margin of BV (0.93%) is comparable to the rest of the industry.
In the last couple of years the Profit Margin of BV has declined.
With a Operating Margin value of 4.34%, BV perfoms like the industry average, outperforming 44.58% of the companies in the same industry.
In the last couple of years the Operating Margin of BV has declined.
BV has a worse Gross Margin (23.31%) than 67.47% of its industry peers.
BV's Gross Margin has declined in the last couple of years.
Industry RankSector Rank
OM 4.34%
PM (TTM) 0.93%
GM 23.31%
OM growth 3Y4.93%
OM growth 5Y-5.36%
PM growth 3Y-27.02%
PM growth 5Y-17.52%
GM growth 3Y-2.9%
GM growth 5Y-2.54%
BV Yearly Profit, Operating, Gross MarginsBV Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 10 20

3

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BV is destroying value.
Compared to 1 year ago, BV has more shares outstanding
BV has less shares outstanding than it did 5 years ago.
BV has a better debt/assets ratio than last year.
BV Yearly Shares OutstandingBV Yearly Shares OutstandingYearly Shares Outstanding 2017 2018 2019 2020 2021 2022 2023 2024 20M 40M 60M 80M 100M
BV Yearly Total Debt VS Total AssetsBV Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

Based on the Altman-Z score of 1.49, we must say that BV is in the distress zone and has some risk of bankruptcy.
BV's Altman-Z score of 1.49 is on the low side compared to the rest of the industry. BV is outperformed by 65.06% of its industry peers.
BV has a debt to FCF ratio of 7.05. This is a slightly negative value and a sign of low solvency as BV would need 7.05 years to pay back of all of its debts.
Looking at the Debt to FCF ratio, with a value of 7.05, BV is in line with its industry, outperforming 59.04% of the companies in the same industry.
A Debt/Equity ratio of 0.45 indicates that BV is not too dependend on debt financing.
Looking at the Debt to Equity ratio, with a value of 0.45, BV is in line with its industry, outperforming 50.60% of the companies in the same industry.
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 7.05
Altman-Z 1.49
ROIC/WACC0.37
WACC7.74%
BV Yearly LT Debt VS Equity VS FCFBV Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

BV has a Current Ratio of 1.43. This is a normal value and indicates that BV is financially healthy and should not expect problems in meeting its short term obligations.
BV has a worse Current ratio (1.43) than 61.45% of its industry peers.
A Quick Ratio of 1.43 indicates that BV should not have too much problems paying its short term obligations.
BV has a Quick ratio of 1.43. This is comparable to the rest of the industry: BV outperforms 55.42% of its industry peers.
Industry RankSector Rank
Current Ratio 1.43
Quick Ratio 1.43
BV Yearly Current Assets VS Current LiabilitesBV Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

4

3. Growth

3.1 Past

BV shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 32.76%, which is quite impressive.
The Earnings Per Share has been decreasing by -8.19% on average over the past years.
The Revenue has decreased by -1.69% in the past year.
The Revenue has been growing slightly by 2.85% on average over the past years.
EPS 1Y (TTM)32.76%
EPS 3Y-14.5%
EPS 5Y-8.19%
EPS Q2Q%100%
Revenue 1Y (TTM)-1.69%
Revenue growth 3Y2.71%
Revenue growth 5Y2.85%
Sales Q2Q%-4.39%

3.2 Future

BV is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 13.16% yearly.
The Revenue is expected to grow by 2.58% on average over the next years.
EPS Next Y14.41%
EPS Next 2Y14.42%
EPS Next 3Y13.16%
EPS Next 5YN/A
Revenue Next Year0.46%
Revenue Next 2Y2.05%
Revenue Next 3Y2.58%
Revenue Next 5YN/A

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
The Revenue growth rate is stable: in the next years the growth will be about the same than in the last years.
BV Yearly Revenue VS EstimatesBV Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1B 2B 3B
BV Yearly EPS VS EstimatesBV Yearly EPS VS EstimatesYearly EPS VS Estimates 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0.2 0.4 0.6 0.8 1

5

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 17.44, BV is valued on the expensive side.
Compared to the rest of the industry, the Price/Earnings ratio of BV indicates a somewhat cheap valuation: BV is cheaper than 69.88% of the companies listed in the same industry.
Compared to an average S&P500 Price/Earnings ratio of 28.29, BV is valued a bit cheaper.
With a Price/Forward Earnings ratio of 13.68, BV is valued correctly.
Compared to the rest of the industry, the Price/Forward Earnings ratio of BV indicates a somewhat cheap valuation: BV is cheaper than 74.70% of the companies listed in the same industry.
BV's Price/Forward Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 21.08.
Industry RankSector Rank
PE 17.44
Fwd PE 13.68
BV Price Earnings VS Forward Price EarningsBV Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, BV is valued a bit cheaper than 75.90% of the companies in the same industry.
74.70% of the companies in the same industry are more expensive than BV, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 11.36
EV/EBITDA 7.45
BV Per share dataBV EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 10 20

4.3 Compensation for Growth

The PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
A more expensive valuation may be justified as BV's earnings are expected to grow with 13.16% in the coming years.
PEG (NY)1.21
PEG (5Y)N/A
EPS Next 2Y14.42%
EPS Next 3Y13.16%

0

5. Dividend

5.1 Amount

No dividends for BV!.
Industry RankSector Rank
Dividend Yield N/A

BRIGHTVIEW HOLDINGS INC

NYSE:BV (4/17/2025, 8:05:10 PM)

After market: 13.43 0 (0%)

13.43

+0.04 (+0.3%)

Chartmill FA Rating
GICS SectorIndustrials
GICS IndustryGroupCommercial & Professional Services
GICS IndustryCommercial Services & Supplies
Earnings (Last)02-05 2025-02-05/amc
Earnings (Next)05-01 2025-05-01/amc
Inst Owners67.39%
Inst Owner Change0.02%
Ins Owners2.94%
Ins Owner Change0.8%
Market Cap1.28B
Analysts81.11
Price Target19.65 (46.31%)
Short Float %7.65%
Short Ratio7.08
Dividend
Industry RankSector Rank
Dividend Yield N/A
Yearly Dividend0.19
Dividend Growth(5Y)N/A
DP105.51%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-1.32%
Min EPS beat(2)-4.54%
Max EPS beat(2)1.9%
EPS beat(4)2
Avg EPS beat(4)11.75%
Min EPS beat(4)-4.54%
Max EPS beat(4)51.33%
EPS beat(8)4
Avg EPS beat(8)0.15%
EPS beat(12)6
Avg EPS beat(12)6.63%
EPS beat(16)7
Avg EPS beat(16)10.44%
Revenue beat(2)0
Avg Revenue beat(2)-3.51%
Min Revenue beat(2)-4.84%
Max Revenue beat(2)-2.17%
Revenue beat(4)0
Avg Revenue beat(4)-3.52%
Min Revenue beat(4)-4.84%
Max Revenue beat(4)-2.17%
Revenue beat(8)0
Avg Revenue beat(8)-3.48%
Revenue beat(12)2
Avg Revenue beat(12)-2%
Revenue beat(16)4
Avg Revenue beat(16)-1.06%
PT rev (1m)0%
PT rev (3m)3.87%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-1.71%
EPS NY rev (1m)-0.68%
EPS NY rev (3m)-2.12%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.93%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-0.63%
Valuation
Industry RankSector Rank
PE 17.44
Fwd PE 13.68
P/S 0.47
P/FCF 11.36
P/OCF 5.35
P/B 0.72
P/tB N/A
EV/EBITDA 7.45
EPS(TTM)0.77
EY5.73%
EPS(NY)0.98
Fwd EY7.31%
FCF(TTM)1.18
FCFY8.8%
OCF(TTM)2.51
OCFY18.7%
SpS28.69
BVpS18.56
TBVpS-3.46
PEG (NY)1.21
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.77%
ROE 1.43%
ROCE 4.2%
ROIC 2.85%
ROICexc 2.95%
ROICexgc 12.86%
OM 4.34%
PM (TTM) 0.93%
GM 23.31%
FCFM 4.12%
ROA(3y)0.26%
ROA(5y)0.17%
ROE(3y)0.6%
ROE(5y)0.4%
ROIC(3y)2.4%
ROIC(5y)2.06%
ROICexc(3y)2.47%
ROICexc(5y)2.14%
ROICexgc(3y)10.98%
ROICexgc(5y)10.41%
ROCE(3y)3.54%
ROCE(5y)3.05%
ROICexcg growth 3Y-0.5%
ROICexcg growth 5Y-6.24%
ROICexc growth 3Y6.57%
ROICexc growth 5Y-3.78%
OM growth 3Y4.93%
OM growth 5Y-5.36%
PM growth 3Y-27.02%
PM growth 5Y-17.52%
GM growth 3Y-2.9%
GM growth 5Y-2.54%
F-Score6
Asset Turnover0.83
Health
Industry RankSector Rank
Debt/Equity 0.45
Debt/FCF 7.05
Debt/EBITDA 3
Cap/Depr 86.39%
Cap/Sales 4.64%
Interest Coverage 1.83
Cash Conversion 90.22%
Profit Quality 444.49%
Current Ratio 1.43
Quick Ratio 1.43
Altman-Z 1.49
F-Score6
WACC7.74%
ROIC/WACC0.37
Cap/Depr(3y)57.78%
Cap/Depr(5y)51.34%
Cap/Sales(3y)3.08%
Cap/Sales(5y)2.78%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)32.76%
EPS 3Y-14.5%
EPS 5Y-8.19%
EPS Q2Q%100%
EPS Next Y14.41%
EPS Next 2Y14.42%
EPS Next 3Y13.16%
EPS Next 5YN/A
Revenue 1Y (TTM)-1.69%
Revenue growth 3Y2.71%
Revenue growth 5Y2.85%
Sales Q2Q%-4.39%
Revenue Next Year0.46%
Revenue Next 2Y2.05%
Revenue Next 3Y2.58%
Revenue Next 5YN/A
EBIT growth 1Y22.83%
EBIT growth 3Y7.78%
EBIT growth 5Y-2.67%
EBIT Next Year75.61%
EBIT Next 3Y25.97%
EBIT Next 5YN/A
FCF growth 1Y1920.97%
FCF growth 3Y13.41%
FCF growth 5Y9.77%
OCF growth 1Y140.62%
OCF growth 3Y11.48%
OCF growth 5Y3.91%